PEPGEN INC. Gain (Loss) on Disposition of Assets
PEPGEN INC. (PEPG) reported Gain (Loss) on Disposition of Assets of -$134.00 thousand for the 12-month period ending 2022-12-31, per its 10-K/A filed 2024-03-29.
Discontinued › Income Statement
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2024-03-29
- PEPGEN INC. gain (loss) on disposition of assets for fiscal 2022 was -$134.00K.
| Period end | Gain (Loss) on Disposition of Assets 12 month |
|---|---|
| 2022-12-31 | -$134.00K 10-K/A · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |